Threats
Researchers raise election safety concerns over lax flexibility in voting, registration policies
There are ways to conduct safe elections even during a pandemic like COVID-19, but despite lessons provided by recent primary elections, researchers from RAND warn that nine states have adopted no policies key to safe voter participation in the 2020 presidential election. This lack of... Read More »
NIH creates AI-based effort to fuel early detection and treatment efforts for COVID-19
The National Institutes of Health (NIH) launched the Medical Imaging and Data Resource Center (MIDRC) this week, beginning a new effort to fight the COVID-19 pandemic through a mix of artificial intelligence-created tools and medical imaging. MIDRC is a collaboration of multiple institutions,... Read More »
NTI report looks at the importance of cybersecurity at nuclear facilities
The Nuclear Threat Initiative’s NTI Index shows that only 47 percent of countries have a response plan in place for a cyberattack on a nuclear facility. Further, NTI reveals that most of those nations do not have adequate regulations for cybersecurity. The NTI Index found that only 34 percent... Read More »
Battelle offers PPE decontamination service to healthcare workers in Hawaii
Battelle is providing a service to healthcare workers in Hawaii to sterilize personal protective equipment (PPE). Any healthcare provider in the state qualifies for the free decontamination service. The masks are decontaminated through Battelle’s process, called the Critical Care... Read More »
Problem Solvers Caucus backs COVID-19 PREPARE Act
The House Problem Solvers Caucus has endorsed the COVID Preparedness, Response, and Effective Planning for Advanced Requirements by the Executive Branch (PREPARE) Act, a bill introduced by Reps. John Katko (R-NY) and Brad Schneider (D-IL). The Problem Solvers Caucus is a bipartisan group in... Read More »
Rep. Graves sponsored several cybersecurity bills that were approved by House
U.S. Rep. Tom Graves (R-GA) sponsored or cosponsored several cybersecurity bills that were passed recently by the U.S. House of Representatives in various funding bills. Graves worked to include a dozen cybersecurity related priorities in more than half of the 12 funding bills, which now move... Read More »
Measure targets PFAS firefighting foam alternative
A group of lawmakers recently introduced a bill they said is designed to find an alternative to PFAS contaminated firefighting foam. Reps. Madeleine Dean (D-PA), Mike Gallagher (R-WI), Andy Kim (D-NJ), Dan Kildee (D-MI) and Chrissy Houlahan (D-PA) said the PFAS Free Foam Research and... Read More »
House EASE Act pushes protections for both in-person, mail-in voters
As the White House and states tussle over mail-in voting, U.S. Rep. Don Young (R-AK) introduced a bill this week known as the Emergency Assistance for Safe Elections (EASE) Act, which proposes to ensure safety at the polls and accuracy in mail-in counts. “The November election is fast... Read More »
NIAID to launch phase 2 clinical trial of experimental therapeutics aimed at mild, moderate COVID-19 cases
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) will lead a phase 2 clinical trial -- ACTIV-2 -- of experimental therapeutics, to see how an antibody-based treatment and others may fare against those with mild to moderate cases of COVID-19. Mild to moderate, in... Read More »
Bill seeks to proactively address threats of imminent violence
Reps. Michael McCaul (R-TX) and Jim Langevin (D-RI) introduced this week a measure designed to streamline the information transfer on imminent violence threats, whether the intent is to harm oneself or others. The Protecting America through Information Sharing Act empowers the Department of... Read More »
Collaboration to yield Iron Dome Weapon System production facility
Raytheon Missiles & Defense officials said the firm has partnered with the Israeli-based defense technology company RAFAEL Advanced Defense Systems Ltd. to establish a domestic Iron Dome Weapon System production facility. "This will be the first Iron Dome all-up-round facility outside of Israel,... Read More »
Researchers develop antiviral compounds
The American Association for the Advancement of Science (AAAS) maintains researchers have engineered antiviral compounds proven to kill several types of coronaviruses in both cells and mice. The work has also proven effective against SARS-CoV-2, the virus that causes COVID-19. The compounds... Read More »
Center for American Progress outlines COVID-19 vaccine manufacturing, distribution plan
Rapid manufacturing and distribution of a COVID-19 vaccine will rank as one of the most challenging U.S. government initiatives ever undertaken, though it can successfully happen with aggressive planning, management, and funding, concludes a newly released report that includes a powerful indictment... Read More »
Study looks at effectiveness of travel bans on slowing COVID-19 spread in Europe
A study by the International Institute for Applied Systems Analysis (IIASA) examined the effectiveness of government travel bans in Europe on slowing the spread of COVID-19. The study found that international flight connections played a particularly important role in the early stages of the... Read More »
University of Texas researchers find mutation that led to 2015-2016 Zika outbreak
A team from The University of Texas Medical Branch at Galveston has found a Zika virus mutation that may be responsible for the outbreak that occurred in 2015 and 2016. Mosquitoes primarily transmit the Zika virus. Because it circulates between mosquitoes and animals/humans, they are prone to... Read More »
DoD and Air Force host virtual “Hack-a-Sat” challenge
The U.S. Department of the Air Force and Department of Defense are hosting a virtual event for cybersecurity professionals on securing space systems. The Space Security Challenge 2020, which will run Aug. 7-9, features a mixture of virtual workshops and prize challenges along with a live... Read More »
Johns Hopkins researchers get $35M grant to test COVID-19 outpatient treatment
The U.S. Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) awarded Johns Hopkins researchers $35 million for clinical trials to test a convalescent blood plasma outpatient treatment to fight COVID-19. The treatment... Read More »
Inovio’s COVID-19 vaccine candidate shows promise in trials
Inovio, a biotechnology company, revealed that its COVID-19 vaccine candidate, INO-4800, was effective in protecting non-human primates, specifically rhesus macaques, from the virus 13 weeks after the last vaccination. These results demonstrate that vaccine candidates reduced viral load in... Read More »
Report examines nuclear weapons modernization costs
Findings from a Government Accountability Office (GAO) analysis requested by a pair of lawmakers determined nuclear weapons modernization costs will be larger than estimated unless programs are scaled or scrapped. Sens. Dianne Feinstein (D-CA) and Edward J. Markey (D-MA) requested the GAO... Read More »
TSA initiates new traveler ID technology
The Transportation Security Administration (TSA) has initiated new technology at John F. Kennedy International and LaGuardia Airports capable of validating traveler identification and confirming flight information in near real-time. The TSA said JFK International Airport has 22 credential... Read More »
NIH invests $248.7M into seven companies for COVID-19 tests
The National Institutes of Health (NIH) announced last week that it will award $248.7 million worth of contracts to seven biomedical diagnostic companies for new COVID-19 tests capable of increasing the number, type, and availability of tests by millions per week in short order. With the need... Read More »
DHS S&T, EPA and Coast Guard team up to combat potential anthrax attack
Recognizing the threat of both natural and terrorist-directed anthrax, the U.S. Coast Guard recently undertook its first decontamination field test to determine the best method of decontaminating facilities and vessels exposed to the deadly disease. This was facilitated by the Analysis for... Read More »
BARDA reaches deal with Regeneron for Ebola treatment
The Biomedical Advanced Research and Development Authority (BARDA) has reached an agreement with Regeneron Pharmaceuticals to procure Ebola virus treatment as part of the U.S. Department of Health and Human Services' (HHS) effort to prepare for public health emergencies. The treatment, known as... Read More »
U.S. to pay $2.1 billion for 100 million doses of coronavirus vaccine from Sanofi and GSK
Under an agreement reached with global biopharmaceutical companies Sanofi and GSK, the U.S. government will pay as much as $2.1 billion for development and delivery of 100 million doses of a vaccine to combat COVID-19. It’s the largest agreement yet negotiated by Operation Warp Speed and it... Read More »
House committee approves bill to authorize U.S. participation in CEPI
The U.S. House Foreign Affairs Committee approved a bill this week that would authorize U.S. participation in the Coalition for Epidemic Preparedness Innovations (CEPI), a public-private partnership developing vaccines for coronavirus and other infectious pathogens. The legislation, the Securing... Read More »
Bill addresses hospital, CDC data collection
A trio of lawmakers have introduced a measure reversing the Trump administration’s directive regarding hospitals withholding coronavirus pandemic data from the Centers for Disease Control and Prevention (CDC). Sens. Dianne Feinstein (D-CA), Sheldon Whitehouse (D-RI) and Jack Reed (D-RI) said... Read More »
In primates, Johnson & Johnson COVID-19 vaccine provides strong protection after one dose
In pre-clinical data recently published in Nature, Johnson & Johnson’s lead vaccine candidate for SARS-CoV-2, the virus that causes COVID-19, provoked strong antibody responses in non-human primates, subsequently blocking infection of their lungs. “We are excited to see these pre-clinical... Read More »Center for Health Security calls for changes in U.S. COVID-19 response in new report
As COVID-19 caused deaths in the United States have crossed 150,000, the Center for Health Security has released a report noting policy actions and data reporting needed at all levels of government to effectively turn the tide against the pandemic. “Unlike many countries in the world, the... Read More »
ATAC secures Air Force training pact
The Air Force has awarded a contract worth up to a combined $240 million to Airborne Tactical Advantage Company (ATAC) for adversary air live training. Air Force officials said the award to ATAC, part of the Textron Systems segment of Textron Inc., is via the Combat Air Forces (CAF) Contracted... Read More »
DOE, HHS, and VA join forces to create COVID-19 Insights Partnership
The Department of Energy (DOE), U.S. Department of Health and Human Services (HHS), and Department of Veterans Affairs (VA) are working together to share health data as well as research and expertise to aid in the fight against COVID-19. The initiative between these three government agencies is... Read More »
Curtiss-Wright secures Navy pact
The Curtiss-Wright Corp. has secured a U.S. Navy contract in excess of $220 million to support a series of naval defense platforms. The initiative includes providing propulsion valves, pumps and advanced instrumentation and control systems for the Navy’s Virginia-class nuclear powered attack... Read More »NIAID scientists report Moderna COVID-19 vaccine boosts immune responses in primate airways
A COVID-19 vaccine candidate -- mRNA-1273 -- produced by Moderna, Inc. and the National Institute of Allergy and Infectious Diseases (NIAID) brought broad immune responses and protection to the upper and lower airways of nonhuman primates, NIAID scientists reported this week. After two doses of... Read More »
Infectious disease experts cite pros, cons of Senate GOP pandemic relief bill
A proposed COVID-19 appropriations bill released on Monday by U.S. Senate Republicans takes solid steps toward providing urgently needed relief and resources, but it also falls short of necessary responses, according to the Infectious Diseases Society of America (IDSA) and the HIV Medicine... Read More »
Pfizer and BioNTech pick lead COVID-19 vaccine candidate for late stage trial
Following review of pre-clinical and phase 1/2 clinical trial data, Pfizer Inc. and BioNTech SE have selected a single mRNA vaccine candidate from the BNT162 program for use against SARS-CoV-2 -- the virus that causes COVID-19 -- in a global phase 2/3 safety and efficacy trial. Investigators... Read More »